# A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics, With Target Occupancy Study of BIIB113 in Healthy Participants

> **NCT05195008** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 72 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** BIIB113
- **DRUG:** BIIB113-Matching Placebo
- **DRUG:** 11^C]BIO-1819578

## Key facts

- **NCT ID:** NCT05195008
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-24
- **Primary completion:** 2023-07-10
- **Final completion:** 2023-07-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05195008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05195008, "A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics, With Target Occupancy Study of BIIB113 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05195008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*